Insulin Degludec: Pharmacokinetic Properties in Subjects with Hepatic Impairment

BACKGROUND AND OBJECTIVE: Insulin degludec is a basal insulin with a slow and distinct absorption mechanism resulting in an ultra-long, flat, and stable pharmacokinetic profile in patients with diabetes mellitus. The aim of this study was to examine the effect of hepatic impairment on the single-dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupčová, Viera, Arold, Gerhard, Roepstorff, Carsten, Højbjerre, Malene, Klim, Søren, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899454/
https://www.ncbi.nlm.nih.gov/pubmed/24277680
http://dx.doi.org/10.1007/s40261-013-0154-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899454/
https://www.ncbi.nlm.nih.gov/pubmed/24277680
http://dx.doi.org/10.1007/s40261-013-0154-1

Ejemplares similares